Titanocene modulation of cytokine imbalance induced by Ehrlich ascites tumour progression

European Journal of Pharmacology

Volumn 503, Issue 1-3, 2004, Pages 203-208

  Valadares, Marize C ^a   Klein, Stanley I ^b   Queiroz, Mary L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cytokine; Ehrlich ascites; Titanocene

Indexed keywords

BISCYCLOPENTADIENYLDICHLOROTITANIUM; BISCYCLOPENTADIENYLDITHIOCYANATE TITANIUM; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TITANOCENE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE IMBALANCE; EHRLICH ASCITES TUMOR; ELECTROLYTE DISTURBANCE; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CYTOKINES; DISEASE PROGRESSION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; SPLEEN; TH1 CELLS; TH2 CELLS; TITANIUM;

EID: 7444270908     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.08.047     Document Type: Article

References (30)

1. K. Abe, M. Harada, K. Tamada, O. Ito, T. Li, and K. Nomoto Early-appearing tumor-infiltrating natural killer cells play an important role in the nitric oxide production of tumor-associated macrophages through their interferon production Cancer Immunol. Immunother. 45 1998 225 233
2. J.M. Birmingham, and G. Wilkinson Bis-cyclopentadyenyl compounds of Ti, Zr, V, Nb and Ta J. Am. Chem. Soc. 76 1954 4281 4284
3. C.V. Christodoulou, A.G. Eliopoulos, L.S. Young, L. Hodgkins, D.R. Ferry, and D.J. Kerr Anti-proliferative activity and mechanism of action of titanocene dichloride Br. J. Cancer 77 1998 2088 2097
4. I. Contasta, A.M. Berghella, P. Pellegrini, and D. Adorno Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions Cancer Biother. Radiopharm. 18 2003 549 557
5. R.J. da-Silva, M.G. da Silva, L.C. Vilela, and D. Fecchio Cytokine profile of Ehrlich ascites tumor treated with Bothrops jararaca venom Mediat. Inflamm. 11 2002 197 201
6. A. Elexpuru, J. Martin-Nieto, A. Jimenez, C. Gomez, and A. Villalobo Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGFbeta)-like activity but lack receptors with TGFbeta-binding capacity Mol. Cell. Biochem. 170 1997 153 162
7. + T cell-dependent tumor eradication in vivo J. Immunol. 2000 5495 5501
8. M. Friedrich, C. Villena-Heinsen, C. Farnhammer, and W. Schmidt Effects of vinorelbine and titanocene dichloride on human tumour xenografts in nude mice Eur. J. Gynaecol. Oncol. 19 1998 333 337
9. B. Halak, K. Henry, C. Maguire Jr., and E.C. Lattime Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site Cancer Res. 59 1999 911 917
10. S.N. Hayakawa, M. Takigawa, and Y. Tokura Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity Immunology 103 2001 449 457
11. W.S. Hodsdon, H. Luzze, T.J. Hurst, M.A. Quigley, J. Kyosiimire, P.B. Namujju, J.L. Johnson, P. Kaleebu, A. Okwera, and A.M. Elliott HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosis AIDS 15 2001 467 475
12. + T cells in the anti-tumor response J. Exp. Med. 1998 2357 2368
13. P. Kopf-Maier Tumour inhibition by Titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract Cancer Chemother. Pharmacol. 23 1989 225 230
14. P. Kopf-Maier Antitumour activity of titanocene in xenografted human renal-cell carcinoma Anticancer Res. 19 1999 493 506
15. N. Kundu, and A.M. Fulton Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis Cell. Immunol. 180 1997 55 61
16. H.I. Levitsky, A. Lazenby, R.J. Hayashi, and D.M. Pardoll In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression J. Exp. Med. 179 1994 1215 1224
17. H. Maeda, and A. Shiraishi TGF-contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice J. Immunol. 156 1996 73 78
18. E. Melendez Titanium complexes in cancer treatment Crit. Rev. Oncol./Hematol. 42 2002 309 315
19. T. Nishimura, K. Iwakabe, M. Sekimoto, Y. Ohmi, T. Yahata, and M. Nakui Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo J. Exp. Med. 1999 617 627
20. B.C.D. Pereira, and S.I. Klein Factors of influence in the activity of titanocenes in the homogenous catalyses of polymerization of polystyrene Eclética Quím. 25 2000 199 212
21. L. Piemonti, A. Zerbi, and V. Di Carlo Strategies for tumor immune escape Drugs Today 39 2003 701 724
22. M.L.S. Queiroz, M.C. Valadares, and C. Bincoletto Ehrlich ascites tumor as a tool in the development of compounds with immunomodulatory properties Immunopharmacol. Immunotoxicol. 26 4 2004 In press
23. T. Schuler, Z. Qin, S. Ibe, N. Noben-Trauth, and T. Blankenstein T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice J. Exp. Med. 189 1999 803 810
24. J.A. Segura, L.G. Barbero, and J. MÁrques Early tumour effect on splenic Th lymphocytes in mice FEBS Lett. 414 1997 1 6
25. J.A. Segura, L.G. Barbero, and J. MÁrques Ehrlich ascites tumour unbalances splenic populations and reduces responsiveness of T cells to Staphylococus aureus enterotoxin B stimulation Immunol. Lett. 74 2000 111 115
26. 2, on the haematopoietic response of Ehrlich tumour-bearing mice Eur. J. Pharmacol. 439 2002 35 42
27. M.C. Valadares, S.I. Klein, S.B. Zyngier, and M.L.S. Queiroz Growth and differentiation of bone marrow haematopoietic cells in mice bearing Ehrlich ascites tumour and treated with dycyclopentadienyildichlorotitanium (IV) Int. J. Immunopharmacol. 20 1998 573 581
28. M.C. Valadares, S.I. Klein, A.M. Guaraldo, and M.L. Queiroz Enhancement of natural killer cell function by titanocenes in mice bearing Ehrlich ascites tumour Eur. J. Pharmacol. 473 2003 191 196
29. J. Wagstaff, J.W. Baars, G.J Wolbink, K. Hoekman, A.J. Eerenberg-Belme, and C.E. Hack Renal cell carcinoma and interleukin-2: a review Eur. J. Cancer 31 1995 401 408
30. N. Yamamoto, J.P. Zou, X.F. Li, H. Takenaka, S. Noda, T. Fujii, S. Ono, Y. Kobayashi, N. Mukaida, K. Matsushima, H. Fujiwara, and T. Hamaoka Regulatory mechanisms for production of IFN-γ and TNF by antitumour T-cells or macrophages in the tumour-bearing state J. Immunol. 154 1995 2281 2290